Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq
Rhea-AI Summary
Caring Brands (NASDAQ:CABR) priced an underwritten public offering of 1,000,000 common shares at $4.00 per share for gross proceeds of approximately $4,000,000, with a 45-day underwriter option to buy up to 150,000 additional shares. The offering is expected to close on November 14, 2025. The company received approval to list common shares on the Nasdaq Capital Market, with trading expected to begin on or around November 13, 2025, at which point shares will cease trading on the OTCQB. Proceeds are intended for general working capital, marketing and sales of proprietary products, and repayment of certain debt. The S-1 was declared effective on October 30, 2025.
Positive
- Priced $4.0M offering: 1,000,000 shares at $4.00
- Nasdaq Capital Markets listing approved; trading around Nov 13, 2025
- 45-day option for 150,000 additional shares granted to underwriters
- Proceeds allocated to marketing, sales, working capital, and debt repayment
Negative
- Immediate dilution from 1,000,000 new shares issued
- Up to 15% additional dilution if 150,000 option shares exercised
- Proceeds partly allocated to debt repayment rather than growth investments
News Market Reaction 59 Alerts
On the day this news was published, CABR declined 54.43%, reflecting a significant negative market reaction. Argus tracked a trough of -54.7% from its starting point during tracking. Our momentum scanner triggered 59 alerts that day, indicating high trading interest and price volatility. This price movement removed approximately $48M from the company's valuation, bringing the market cap to $40M at that time.
Data tracked by StockTitan Argus on the day of publication.
FORT PIERCE, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the pricing of its underwritten U.S. public offering of 1,000,000 common shares at a public offering price of
In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 150,000 common shares at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on November 14, 2025, subject to customary closing conditions.
In connection with the Offering, Caring Brands has received approval to list its common shares on the Nasdaq Capital Markets, with the shares expected to begin trading on or around the date of November 13, 2025 under the symbol “CABR”, at which point our common stock will cease to be traded on the OTCQB.
Caring Brands intends to use the net proceeds received from this offering for general and working capital purposes, including but not limited to marketing and sales of its proprietary products, and for the repayment of certain debt.
D. Boral Capital LLC (“D. Boral”) is acting as the sole underwriter in connection with this offering.
A registration statement on Form S-1 relating to the Offering, as amended, was filed with the Securities and Exchange Commission (the “SEC”) (File Number: 333-289767) and was automatically declared effective on October 30, 2025. The Offering is being made only by means of a prospectus. A copy of the final prospectus will be filed with the SEC, which may be obtained, when available, from D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022 by email to info@dboralcapital.com, or by calling (212) 970-5150.
Before you invest, you should read the registration statement, the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any offer, solicitation or sale of such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Caring Brands, Inc.
Caring Brands is a wellness consumer products company who offers several over-the-counter (OTC) and cosmetic consumer products. The Company’s product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, and a jellyfish sting protective suncare line catering to diverse health and wellness needs. The Company’s method of operation ensures that the mechanism of action of all products is established, efficacy is determined through controlled clinical trials, products are protected by issued and filed patents, and products have acceptable commercial stability.
Forward-Looking Statement
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the proposed Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “believe”, “plan”, “expect”, “intend”, “should”, “seek”, “estimate”, “will”, “aim” and “anticipate” or other similar expressions in the prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.
For further information, please contact:
Brian S John
(561) 896-7616
FAQ
What did CABR announce about its public offering on November 13, 2025?
When will CABR begin trading on Nasdaq and stop OTCQB trading?
How does Caring Brands intend to use the net proceeds from the CABR offering?
Who is the underwriter for the CABR offering and what option was granted?
When was the S-1 registration for CABR declared effective by the SEC?
